乙型肝炎孕期抗病毒治疗对母婴结局的影响

乙型肝炎病毒感染的妇女孕期抗病毒治疗不仅在于疾病本身的治疗,还在于阻断宫内垂直传播。临床应重视孕期根据母体病毒载量及肝病的严重程度关注抗病毒时机和药物选择,以获得良好的妊娠结局。

Antiretroviral therapy for hepatitis B virus carrier during pregnancy may not only cure the disease, hut also interrupt intrauterine transmission of hepatitis B virus. The patients during pregnancy should be emphasized, on the basis of maternal serum viral loads and severity of the liver disease, optimal antiviral therapy time and antiviral agents are chosen to achieve favorable pregnancy outcome.